Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

3.00
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
0.50
Today|||52-Week Range
4.24
+7.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-107.0M-52.7M-15.0M-26.9M
 
 
 
 
 
Depreciation3.8M6.2M9.6M30.0K
 
 
 
 
 
Total Other Cash Flow5.4M10.8M2.3M-3.3M
 
 
 
 
 
Funds From Operations-97.8M-35.7M-3.1M-30.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-13.4M19.2M18.1M936.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-84.4M-54.8M-21.2M-31.1M
 
 
 
 
 
 
InvestingIncrease In Investments-175.4M-42.3M-19.1M-29.4M
 
 
 
 
 
Decrease In Investments191.1M109.8M11.6M28.7M
 
 
 
 
 
Capital Expenditures-3.7M-12.9M-22.0K-7.0K
 
 
 
 
 
Fixed Asset Disposal--191.0K1.2M0.00
 
 
 
Net Cash Flow Investing12.1M54.7M-6.3M-764.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings0.008.6M0.004.9M
 
 
 
Long Term Debt Reduction-7.1M-7.8M-11.6M0.00
 
 
 
 
Net Proceeds Stock Sale53.6M191.0K10.5M15.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing465.0K0.000.000.00
 
 
Other Uses - Financing--0.000.000.00--
Net Cash Flow - Financing47.0M1.0M-1.1M20.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash26.0K0.000.00--
 
 
 
Net Change In Cash-25.3M882.0K-28.7M-11.5M